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Abstract
Background: In addition to mutations, epigenetic silencing of genes has been recognized as a fundamental
mechanism that promotes human carcinogenesis. To date, characterization of epigenetic gene silencing has largely
focused on genes in which silencing is mediated by hypermethylation of promoter-associated CpG islands,
associated with loss of the H3K4me3 chromatin mark. Far less is known about promoters lacking CpG-islands or
genes that are repressed by alternative mechanisms.
Methods: We performed integrative ChIP-chip, DNase-seq, and global gene expression analyses in colon cancer
cells and normal colon mucosa to characterize chromatin features of both CpG-rich and CpG-poor promoters of
genes that undergo silencing in colon cancer.
Results: Epigenetically repressed genes in colon cancer separate into two classes based on retention or loss of
H3K4me3 at transcription start sites. Quantitatively, of transcriptionally repressed genes that lose H3K4me3 in colon
cancer (K4-dependent genes), a large fraction actually lacks CpG islands. Nonetheless, similar to CpG-island
containing genes, cytosines located near the start sites of K4-dependent genes become DNA hypermethylated, and
repressed K4-dependent genes can be reactivated with 5-azacytidine. Moreover, we also show that when the
H3K4me3 mark is retained, silencing of CpG island-associated genes can proceed through an alternative
mechanism in which repressive chromatin marks are recruited.
Conclusions: H3K4me3 equally protects from DNA methylation at both CpG-island and non-CpG island start sites
in colon cancer. Moreover, the results suggest that CpG-rich genes repressed by loss of H3K4me3 and DNA
methylation represent special instances of a more general epigenetic mechanism of gene silencing, one in which
gene silencing is mediated by loss of H3K4me3 and methylation of non-CpG island promoter-associated cytosines.
Background
The development of cancer is closely associated with the
stepwise accumulation of not only somatic mutations,
but also epigenetic alterations that alter chromatin
structure and lead to dysregulated gene expression. Cur-
rent dogma holds that for normal somatic cells, tri-
methylated lysine 4 on histone H3 (H3K4me3)
represents a chromatin landmark that is present at the
transcription start sites (TSSs) of protein-coding genes
that are either actively transcribed or that are held in a
‘poised’ state permissive for gene transcription [1]. How-
ever, it is also well established that during the process of
malignant transformation, loss of H3K4me3 occurs at
TSSs of genes that undergo transcriptional inactivation
as a result of promoter hypermethylation [2,3]. The loss
of H3K4me3 is consistent with a model whereby DNA
methylation at CpG islands is initiated by removal of
H3K4me by LSD1 (lysine-specific demethylase 1) and
JmjC families of demethylases, followed by targeting of
DNA methyltransferase (DNMT)3A/Dnmt3B-Dnmt3L
* Correspondence: sxm10@case.edu; pxs183@case.edu
† Contributed equally
1Department of Genetics and Genome Sciences, Case Western Reserve
University, 10900 Euclid Ave, Cleveland, OH 44106, USA
Full list of author information is available at the end of the article
Balasubramanian et al. Genome Medicine 2012, 4:47
http://genomemedicine.com/content/4/5/47
© 2012 Balasubramanian et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
complexes, which deposit methyl groups [2,4-7]. How-
ever, de novo DNA methylation is an infrequent event
occurring on only a very small fraction of CpG island-
containing promoters. Far less is known about promo-
ters lacking CpG islands or genes that are repressed by
alternative mechanisms, mainly because genome-wide
surveys of epigenetic modifications have only recently
become technically feasible.
Here, we used ChIP-chip and expression analyses to
systematically study the relationship between H3K4me3
and genes that are transcriptionally repressed in colon
cancer compared to normal colon mucosa. We found
that the majority of protein-coding genes contain
H3K4me3, as expected. Interestingly, H3K4me3 is
retained among a set of genes that undergo transcrip-
tional repression, or ‘silencing’ during the process of
malignant transformation. Repressed genes that retain
H3K4me3 are also located in open regions of chromatin
that are hypersensitive to DNaseI digestion, nearly
always contain CpG islands, and frequently acquire his-
tone modifications associated with transcriptional
repression. Consistent with the established inverse cor-
relation between DNA methylation and H3K4me3, we
also detected a class of repressed genes that virtually
lack detectable levels of H3K4me3 and show increased
DNA methylation compared to normal colon mucosa.
While the increased DNA methylation accompanying
loss of H3K4me3 is easily detected at promoters con-
taining CpG islands, we find this increase is often more
prevalent at the scattered CpG sites in the promoters of
genes devoid of CpG islands. We propose a model
whereby H3K4me3 equally protects from DNA methyla-
tion at both CpG island and non-CpG island start sites,
suggesting that the mechanisms associated with DNA
methylation-associated gene silencing in colon cancer
are similar for CpG and non-CpG island-containing
genes.
Materials and methods
Cell lines and tissue samples
The VACO cell lines (VACO429, VACO432, VACO441
and VACO425) were cultured as previously described
[8]. SW480 was obtained from the American Type Cul-
ture Collection. Normal colon mucosa was obtained
from a scraping of fresh resected colon. Cell viability
was examined by staining with Trypan Blue, and esti-
mated at 85 to 95%. Extraction of colonic crypts was
performed by EDTA fractionation. Briefly, colon mucosa
was first dissected from each sample taking care to
maintain tissue integrity. The mucosa was then cut into
thin strips, gently agitated in cell dissociation buffer
(Invitrogen 13151-014 Carlsbad, CA, USA), rinsed in
phosphate-buffered saline, and then agitated in fresh
buffer. The tissue strips were then rapidly pipetted until
the solution became cloudy due to the release of crypts
from the mucosa. Mucosa strips were removed from the
solution and discarded. The remaining solution was
examined microscopically for the presence of viable,
intact crypts free of contaminating debris.
ChIP-chip
Chromatin immunoprecipitation (ChIP)-chip experi-
ments were performed as previously described [9] using
the following antibodies: H3K4 trimethyl (Abcam
ab8580 (Cambridge, MA, USA); Upstate 39159 (Billerica,
MA, USA)), H3K9 dimethyl (Abcam, ab1220), H3K20
trimethyl (Abcam ab9053), and H3K27 trimethyl
(Abcam ab6002). The following three array platforms
were used: (1) NimbleGen (Madison, WI, USA) human
2.1M deluxe promoter arrays; (2) NimbleGen 385K pro-
moter arrays; and (3) Agilent (Santa Clara, CA, USA)
custom tiling arrays. The NimbleGen human 2.1M pro-
moter array contains 50- to 70-mer probes spanning 7.2
kb upstream and 3.2kb downstream of each TSS at a
resolution of 1 oligo per 100 bp. NimbleGen 385K
arrays contain 50- to 70-mer probes spanning 1 kb
upstream and 500 bp downstream of approximately
19,000 TSSs at a resolution of 1 oligo per 100 bp. To
account for potential differences in the dyes on the
array, ChIP/input ratios for each probe were scaled by
subtracting the bi-weight mean for the log-ratio values
from each log-ratio. ChIP-chip signals were then quan-
tile normalized so that separate ChIP-chip experiments
could be directly compared. Agilent microarrays con-
tained 44,000 features, with oligos that spanned 10 kb
downstream and 5 kb upstream of the TSS of the
desired genes. Agilent array data were processed and
normalized using Feature Extraction. For the compari-
son of multiple histone marks between normal colon
mucosa and SW480, ChIP-chip data were processed
with the software package ACME using a window size
of 500 bp and a threshold of 95% [9]. The minimum P-
values for signals located near (±1 kb from each TSS)
were then calculated and plotted.
Expression analyses
RNA was purified by cesium chloride density gradient
centrifugation from all cell lines, normal colon mucosa,
and normal colon crypt preparations. RNA was then
labeled and hybridized to Affymetrix (Santa Clara, CA,
USA) Human Exon 1.0 ST exon arrays according to
standard protocols. All microarray data were processed
in a single batch using the Affymetrix Expression Con-
sole software, obtaining gene level expression data using
‘core’ probe sets (the highest confidence level probe sets,
associated with BLAT alignments of mRNA with anno-
tated full-length coding sequence regions) using median
normalization and the PLIER (probe logarithmic
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intensity error estimation) algorithm. Genes located on
Y, random, and the mitochondrial chromosomes were
excluded. Repressed genes were considered those with
an expression value of <31, while genes with expression
values >75 were considered expressed or ‘on’. These
thresholds were determined through analysis of the dis-
tribution of expression of all genes sampled on the
microarray. K4-independent genes were designated as
those repressed (<31) in the colon cancer cell lines com-
pared to normal colon crypt (>75), and containing
enrichment of H3K4me3 in normal colon mucosa and
colon cancer cell lines at levels corresponding to the
right side of the bimodal distribution of H3K4me3 levels
of all genes. K4-dependent genes were designated as
repressed genes (<31) that showed levels of H3K4me3
corresponding to the left side of the bimodal
distribution.
DNase-seq
DNase-seq was performed as previously described [10].
Sequencing was performed using an Illumina (San
Diego, CA, USA) GAII, and 35-bp reads were obtained
for all samples. Sequences were aligned to the human
genome reference sequence (Hg18) using MAQ [11].
The number of aligned sequence reads were as follows:
SW480, 21,461,814; V432, 16,003,416; V429, 7,110,678.
Aligned sequences were processed with F-seq [12]. The
maximum peak signal within 2 kb of all human TSSs
was then extracted from the genome-wide DNase-seq
profiles, so that each TSS could be assigned a single
score. Scores were Z-score transformed so that indivi-
dual samples could be directly compared.
Methylation analysis
Pyrosequence analysis of bisulfite converted and non-
converted DNA was performed by EpigenDx (Worce-
ster, MA, USA). CpG sites analyzed were located at the
following positions relative to the TSSs of each indicated
gene (HG19 genome assembly): MMP28, (-589, -582,
-563, -536, -504,-486); PTGDR, (55, 58, 68, 86, 124, 126,
130, 148, 150, 153, 162, 166,175); HMGCS2, (59, 78, 98,
125); ACSL5, (22, 28, 55, 97, 117, 150, 154, 176, 200);
BCAS1, (-262, -223, -195, -132); FRK, (-503, -493, -484,
-442, -431); UBA7, (-123, -134); BCL2L14, (55, 19);
PIGR, (-673, -656, -650, -597); CD177, (-150, -6, 5, 7);
GUCY2C, (-124, -161, -126); TNFSF10, (-43, -98);
SEMA6D, (-94, -90, -81, -76, -60, -57, -50, -42);
MOBKL2B, (-77, -71, -67, -54, -50, -47, -41, -39, -30,
-23, -19, -13, -11, -8, -6); SLC39A5, (-297, -218, -162,
-102, -50).
5-Azacytidine treatment
SW480 cells were seeded at 105 per T75 flask on day 0.
The cultures were treated for 24 h on days 2 and 5 with
5-azacytidine at 1 µg/µl. The media was changed 24 h
after the addition on 5-azacytidine (on days 3 and 6).
RNA harvested 8 days after the initial 5-azacytidine
treatment was DNase-treated and purified using the
RNeasy kit (Qiagen, Germantown, MD, USA). cDNA
was prepared using the high capacity cDNA archive kit
(Applied Biosystems, Foster City, CA, USA), and stan-
dard quantitative RT-PCR analyses were performed.
Results
H3K4me3 ChIP-chip in colon cancer cell lines
We performed ChIP studies using microarrays contain-
ing 2.1 million oligonucleotides tiled across all human
promoters to define the repertoire of genes containing
H3K4me3. These studies were carried out in five colon
cancer cell lines (SW480, V432, V425, V429, V441) and
normal colon mucosa. A representative view of the
H3K4me3 ChIP-chip data for one of the six samples
tested is shown in Additional file 1. Similar to previous
studies in human embryonic stem cells, primary hepato-
cytes and B cells [1], we found that the majority (57 to
66%) of all annotated promoters in colon were enriched
for H3K4me3 at medium to high confidence (Figure 1a,
b). Next we plotted the levels of H3K4me3 for all genes
as a histogram. The data show a bimodal distribution
with peaks at genes that have robust levels (right side of
distribution) and weak or absent levels (left side of dis-
tribution) of H3K4me3 (Figure 1c). Examples of genes
with H3K4me3 enrichment values at either peak of the
bimodal distribution are shown in Figure 1c. Lastly, we
performed a cluster analysis of the H3K4me3 promoter
signals across all six samples. The results indicate that
while the majority of promoters show similar H3K4me3
levels among different individual samples, a small frac-
tion of promoter-specific differences between individuals
are clearly apparent (Figure 1d).
Repressed genes can be distinguished into two classes,
based on the presence or absence of H3K4me3
We next set out to identify genes that are repressed in
each of the colon cancer samples compared to normal
colon mucosa. For these experiments, we prepared RNA
from each of the five colon cancer cell lines, as well as
microdissected histologically normal colon mucosa, and
five individual preparations of epithelial crypts purified
by fractionation from normal colon mucosa. Samples
were hybridized to Affymetrix Human Exon 1.0 ST
Arrays, which are known to be more reliable for tran-
script quantification than standard 3’-UTR microarrays.
Similarly to the H3K4me3 data, the genome-wide distri-
bution of gene expression is largely bimodal (Additional
file 2A). This allowed us to divide genes into two main
categories: (1) abundantly expressed or ‘on’; and (2) near
background levels or ‘off’. Among all samples analyzed,
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we found that, on average, 49% of genes were expressed
and 33% of genes were off; 18% of genes fell in the
trough of the bimodal distribution and could not be
neatly classified as either silent or expressed.
Having identified the list of expressed and repressed
genes, the next step was to merge the expression data to
the ChIP-chip data. Because expression and ChIP-chip
analyses were performed using different platforms, only
genes represented on both platforms could be utilized
for the combined analysis. Nevertheless, we identified
>15,000 unique genes for which we had obtained both
expression and H3K4me3 ChIP-chip data. We observed
a high correlation between the expression and
H3K4me3 levels in each of the cell lines (Additional file
2B). Using the combined datasets, we looked for genes
that showed high expression and high levels of
H3K4me3 in the normal colon samples, and were
repressed in any one of the five colon cancer cell lines;
1,085 genes fit these criteria. We then examined the




Figure 1 ChIP-chip of H3K4me3. (a) Enrichment of H3K4me3 within 2 kb of all human TSSs. (b) Maximum enrichment of H3K4me3 within 1
Kb of the TSS for each human gene. Genes are ordered similarly to (a). (c) Histogram of H3K4me3 signals at all human TSSs. The vertical lines
correspond to thresholds used to distinguish genes containing high levels of H3K4me3 (right-side of the distribution) from genes containing low
H3K4me3 levels (left side of the distribution). Genes falling between the two vertical lines are indeterminate and not designated as K4-absent or
K4-present genes. The bottom panel shows an example of a gene lacking H3K4me3 (CD247), and a gene containing H3K4me3 (UCK2). (d)
Maximum H3K4me3 signal at all TSSs in the five colorectal cell lines (SW480, V432, V425, V429, V441) and normal colon mucosa. Columns
represent individual samples, and rows represent H3K4me3 signals at TSSs. Dark blue corresponds to high H3K4me3 enrichment; light blue
corresponds to little or no enrichment.
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line. Surprisingly, a large portion of repressed genes (41
to 76%) contained significant levels of H3K4me3, while
a much smaller fraction (15 to 34%) showed nearly
absent levels of H3K4me3. We designated repressed
genes that retain H3K4me3 as K4-independent and
repressed genes that lose H3K4me3 as K4-dependent.
The total number of K4-dependent and -independent
genes varied substantially between each cell line,
although in all samples more K4-independent genes
were detected than K4-dependent genes (Figure 2a).
Additionally, while there were some examples of genes
that were repressed among all five colon cancer cell
lines, by and large the identity of genes repressed dif-
fered between lines (Figure 2b). Despite this, genes
designated as either K4-dependent or -independent in a
given line generally showed the same designation when
again repressed in any of the remaining five lines. While
generally true, some exceptions to this generalization
could be identified, that is, some K4-dependent genes
were classified as K4-independent in a different line, and
vice versa. This variability likely reflects molecular het-
erogeneity among the colon samples.
Verification of K4-dependent and K4-independent classes
The levels of H3K4me3 for genes in each class were
validated by standard ChIP on biological replicate sam-
ples (Additional file 3A). The loss of the H3K4me3 sig-
nal at K4-dependent genes cannot be due to
homozygous deletions, as these regions could be suc-
cessfully amplified by genomic PCR. For further
verification, we performed hybridizations of H3K4me3
ChIPs from samples V425, V432, V441, SW480 and two
independent preparations of normal colon mucosa to
NimbleGen 385K promoter arrays and repeated the data
analysis. Consistent with the previous results, both K4-
dependent and -independent genes were evident, and
the relative proportions of each class were similar within
and between each cell line to the proportions found
using the 2.1M feature arrays (Additional file 4A). Next,
we examined the exon-tiling array data to confirm that
genes designated as repressed were in fact repressed
across all exons, and that when expressed in the crypt
were expressed across all exons, consistent with the
canonical transcript from the locus. We found that,
compared to genes in crypt that were designated as ‘on’,
and that conformed to the canonical transcript and its
associated promoter, the expression levels across all
exons of genes designated as repressed were at or near
background levels. The exon usage across a representa-
tive example of a repressed gene is shown in Additional
file 4B. Lastly, we investigated whether K4-dependent
and K4-independent genes repressed in cell culture were
similarly under-expressed in primary tumors. Using glo-
bal expression data, we first selected K4-dependent and
K4-independent genes that were repressed by at least
two-fold in all five colon cancer cell lines relative to five
epithelial colon crypt samples. We then determined the
percentage of these genes that were also repressed in
120 primary tumors relative to 16 normal mucosa sam-
ples. Of all genes, only 7.7% of genes repressed in the
cell lines are also repressed in tumors relative to
mucosa, whereas 76% of K4-dependent and K4-indepen-
dent genes repressed in cancer cell lines validated as
repressed in primary tumors (P < 2.2 × 10-16 by exact
binomial test). Collectively, these data strongly support
the existence of the two classes of repressed genes in
colon cancer, indicate that alternative promoter usage is
unlikely to account for the difference in H3K4me3 sta-
tus between the two classes, and suggest that most
genes identified as repressed in the cell culture models
are genuinely repressed in colon cancer.
K4-dependent and -independent genes show differences
in chromatin structure
We mapped open regions of chromatin in three of the
five colon cancer lines (SW480 VACO432, and
VACO429) using the technique of DNase-seq [10]. Each
promoter was then assigned a score corresponding to
the relative sensitivity to DNaseI digestion, and the data
were merged to the H3K4me3 ChIP-chip data and
expression data. We then tested whether promoters of
K4-containing expressed genes, K4-dependent repressed
genes, and K4-independent repressed genes differ in












Figure 2 Designation of K4-dependent and K4-independent
genes in colon cancer. (a) Bar plot showing proportions of K4-
dependent and K4-independent genes in each of the five colon
cancer cell lines. (b) Heatmap integrating H3K4me3 ChIP-chip
signals and corresponding transcript levels. Blue, expressed and
H3K4me3 present; red, not expressed and H3K4me3 present; green,
not expressed and H3K4me3 absent; white, H3K4me3 status not
classifiable.
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containing expressed genes were significantly more sen-
sitive to DNaseI digestion than both classes of repressed
genes in all three cell lines (P < 5.7e-8; Figure 3). Of the
two classes of repressed genes, K4-independent genes
were significantly more sensitive to DNaseI digestion
than K4-dependent genes (P < 0.0002). Specifically, 75
to 90% of genes designated as K4-independent were
located within open chromatin, compared to 22 to 53%
of K4-dependent promoters. Thus, compared to K4-
independent genes, the promoters of repressed genes
lacking H3K4me3 are generally located within relatively
inaccessible conformations of chromatin.
K4-dependent genes show DNA hypermethylation
We next looked for the presence of CpG islands within
2 kb of the TSSs of K4-dependent and -independent
genes; 95 to 99% of K4-independent genes were found
to have a CpG island, compared to 33 to 56% of K4-
dependent genes (Additional file 5). We noticed that
several genes designated as K4-dependent in our study,
including CDX1, BMP3, and MLH1, were previously
reported to show CpG island promoter
hypermethylation [13-15]. These findings prompted us
to test whether K4-dependent genes lacking CpG islands
also showed promoter hypermethylation. We performed
pyrosequencing of bisulfite converted DNA to quantify
DNA methylation at K4-dependent and K4-independent
genes in cell lines in which these genes were repressed.
As controls, these genes were also analyzed in three
independent preparations of purified normal colon
crypts. The pyrosequencing assays were designed to
interrogate CpG sites located under the H3K4me3 peak
of each gene, in close proximity (<700 bp) to the TSS.
Nine of eleven K4-dependent repressed genes showed
dramatic increases in DNA methylation over levels
detected in normal colon crypt (Figure 4a-c). Moreover,
several genes, including PIGR, CD177, and HMGCS2,
were hypermethylated in more than one cell line in
which these genes were designated as K4-dependent. In
summary, 15 out of 19 assays performed on K4-depen-
dent genes were positive for DNA hypermethylation. In
comparison, two out of eight pyrosequencing assays per-
formed on K4-independent genes were positive for DNA
hypermethylation. These proportions are significantly
different (P < 0.03 by Z-test for proportions).
We next tested whether K4-dependent genes that lack
CpG islands could be reactivated upon treatment with
5-azacytidine. Three out of four K4-dependent genes
tested showed a significant increase in transcript levels
upon treatment with 5-azacytidine (P ≤ 0.01; Figure 4d),
consistent with hypermethylation of the scattered CpG
sites under the H3K4me3 mark being functionally
involved in these genes’ silencing. The data indicate that
DNA hypermethylated K4-dependent repressed genes
do not necessarily contain CpG islands, and that
repressed K4-dependent genes lacking both CpG islands
and H3K4me3 are very likely to be DNA methylated in
regions that lose the H3K4me3 mark. The results are
also consistent with previously reported reactivation of
hypermethylated genes lacking CpG islands upon treat-
ment with 5-azacytidine [16].
Characterization of histone marks at K4-independent and
K4-dependent genes
We performed ChIP-chip analysis to test whether
repressed genes acquire histone modifications generally
associated with transcriptional repression (H3K9me2,
H3K27me3, and H4K20me3) and, if so, whether these
modifications differ between K4-dependent and -indepen-
dent genes. These studies were performed using custom-
designed tiled arrays spanning the promoters and bodies
of 80 genes repressed in colon cancer line SW480. ChIP-
chip signal intensities for each mark and for each gene
promoter were then hierarchically clustered and plotted in
a heatmap. Strikingly, this analysis revealed a near perfect
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Figure 3 Loss of H3K4me3 is associated with resistance to
DNaseI digestion. (a) Representative DNase-seq signals at a K4-
independent (top) and K4-dependent (bottom) gene in cell line
SW480. (b) Box plots depicting relative levels of DNase I
hypersensitivity among expressed (O), K4-independent (I), and K4-
dependent (D) genes.
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classes (Figure 5). Moreover, consistent with data above
indicating that K4-dependent genes often lack CpG
islands, a minority (27%) of genes classified as K4-depen-
dent were found to have a CpG island at the TSS, com-
pared to nearly all (>95%) of the genes classified as K4-
independent. In addition, we found that genes associated
with repressive histone marks, including H3K27me3,
H4K20me3, and occasionally H3K9me2, were mostly K4-
independent genes in which the H3K4me3 mark had been
retained, or were originally marked with both H3K4me3
and H3K27me3 in colon mucosa, so-called ‘bivalent’ chro-
matin [17]. The presence of H3K27me3 was validated at
several K4-independent genes in SW480, as well as V441
and V429 by standard ChIP (Additional file 3B). Interest-
ingly, with the exception of a few genes in our K4-depen-
dent group that showed low-level acquisition of
H3K27me3 or H3K9me2, the loss of H3K4me3 was
usually not accompanied by any additional chromatin
modifications (other than our finding of increased DNA
methylation). While we currently cannot rule out the
possibility that these K4-dependent genes acquired a
repressive mark that was not tested, the data indicate that
the repertoire of histone marks at K4-dependent and
-independent genes are often distinct.
K4-dependent and -independent genes are functionally
distinct
We used Panther to determine whether specific path-
ways or biological processes are enriched among K4-
dependent and -independent genes, and if so, whether
they differ between the two classes [18]. Intriguingly,
several pathways previously linked to colorectal carcino-
genesis were enriched in the K4-independent set,
including transforming growth factor-beta, insulin and
Wnt signaling (Additional file 6). In contrast, K4-depen-
dent genes were enriched in axon guidance, pyrimidine
metabolism and cadherin signaling. Both classes were
enriched for genes involved in apoptosis and platelet-
derived growth factor signaling, as well as pathways

































































































































































































































































Figure 4 K4-dependent promoters are DNA hypermethylated. (a-c) Percentage DNA methylation of indicated K4-dependent (K4-D) and K4-
independent (K4-I) genes in SW480 (a), V432 (b), and V441 (c). For comparison, methylation levels of genes were also quantified in normal colon
crypts. Error bars indicate the standard deviation of pyrosequencing assays performed on three independent preparations of normal colon
crypts. All K4-independent genes analyzed contain a CpG island at the TSS. All K4-dependent genes, except PTGDR, lack a CpG island at the TSS.
(d) Quantitative RT-PCR analyses of genes from 5-azacytidine (Aza) treated (+) and untreated (-) SW480 cells. Data were normalized to GAPDH.
RHBDL2, UBA7, FUT3, and GUCY2C are K4-dependent genes that lack a CpG island. ZFP42 was previously found in this cell line to be DNA
hypermethylated and reversible upon treatment with 5-azacytidine, and thus serves as a positive control. OVOL1 is a K4-independent gene with
a promoter-associated CpG island and serves as a negative control. Error bars indicate the standard deviation of quantitative RT-PCR reactions
performed in triplicate. *P ≤ 0.01.
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We next tested whether genes in each class show tis-
sue-specific expression in colon crypts, and if so,
whether the degree of crypt-specific expression differed
between the two classes. To do this, we compared glo-
bal gene expression levels between normal colon crypt,
HepG2, K562, and NB4 cells and computed a tissue-
specificity score for each gene using the method of
Shannon entropy [19]. We then plotted the distribu-
tion of colon-specificity scores for K4-dependent and
-independent repressed genes, all genes, and 1,000 ran-
domly selected genes. Both K4-dependent and -inde-
pendent genes showed a high degree of crypt tissue-
specific expression, with K4-dependent genes being
significantly more crypt-specific than K4-independent
genes (P < 0.0001) (Additional file 7A). These findings
are consistent with other studies showing that genes
lacking CpG islands, which comprise a large fraction
of the K4-dependent class of repressed genes, are gen-
erally associated with tissue-specific expression [19].
Lastly, we tested whether K4-dependent genes show
an increased propensity for silencing in colon cancer
compared to K4-independent genes, or vice versa. To
do this, the transcriptional status of genes designated as
K4-dependent or K4-independent in the five colon cell
lines was surveyed in an additional 35 colon cancer cell
lines. We then plotted the distribution of the median
expression values for each set as a histogram (Additional
file 7B). Although the expression of K4-dependent genes
is more variable than K4-independent genes, the overall
distribution of K4-dependent genes is significantly
shifted to the left of that of K4-independent genes (P =
0.015), indicating that K4-dependent genes are repressed
more often in colon cancer than K4-independent genes.
Although confirmatory studies are required, these find-
ings raise the possibility that genes targeted for silencing
in colon cancer are more often inactivated by mechan-
isms involving removal of H3K4me3 than by K4-inde-
pendent mechanisms.
Discussion
In this paper we propose a revision of the commonly
described model of epigenetic silencing of genes in can-
cer. Studies on epigenetic silencing of genes in cancer
have generally focused on silencing by aberrant DNA
methylation of CpG island containing promoters,
accompanied by loss of the H3K4me3 mark. Here, we
show that it is actually non-CpG island-containing
genes that are often characteristically repressed by loss
of the H3K4me3 mark, accompanied by aberrant methy-
lation of scattered CpG residues near the TSS. More-
over, we find that repressed genes containing CpG
islands are most commonly associated with repressive
histone marks, such as H3K27me3, with these genes
retaining H3K4me3. The two classes of repressed genes
are further distinguishable by function and sensitivity to
DNase digestion, with gene promoters losing H3K4me3
located within relatively condensed chromatin compared
to promoters that retain H3K4me3. A model summariz-
ing these findings is shown in Figure 6.
Two studies in which epigenetic silencing marks
were profiled in prostate cancer cells (PC3) revealed
that loci marked with H3K27me3 are devoid of DNA
hypermethylation, raising the possibility that gene
silencing by H3K27me3 occurs independently of pro-
moter methylation [20,21]. These findings are consis-
tent with our results, with one notable exception. The
studies by Kondo et al. [20] indicate that promoters















































































Figure 5 ChIP-chip analysis of multiple histone marks at the
promoters of repressed genes. Plotted in the heatmap are -log10
P-values corresponding to ChIP-chip signal intensities of H3K4me3,
H3K27me3, H3K9me2, and H4K20me3 at the promoters of 80 genes
as measured in SW480 versus normal colon mucosa. The heatmap
reveals two main classes of genes. Most repressed genes designated
as K4-independent retain H3K4me3 (blue color) and gain repressive
histone marks, including H3K27me3 and H4K20me3, which move
from mostly red in normal to blue in the tumor. In contrast, most
repressed genes designated as K4-dependent show loss of
H3K4me3 (with H3K4me3 going from blue in tumor to red in
SW480) and have not acquired any other repressive marks (with the
other marks displayed as red in both the normal and tumor). In
addition, the majority of genes within K4-dependent lack a CpG
island (***no CpG island), while all K4-independent genes have a
CpG island.
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methylation are mostly devoid of CpG islands, while
the data presented here indicate that this trend is far
more prevalent for CpG island-containing promoters.
In fact, only a small fraction of the genes we desig-
nated as K4-dependent, which are frequently devoid of
promoter CpG islands, were found to contain signifi-
cant levels of H3K27me3. The discrepancy between
our results and the published studies is currently not
clear, but could be related to differences in cancer
type.
Previous studies have shown that low CpG promoters
display no significant correlation between gene activity
and the abundance of methylated cytosines [2]. The dis-
crepancy between these findings and our results is likely
due to methodological differences related to transcript
quantification. Here, mRNA transcript levels were
directly quantified using all exon microarrays. In con-
trast, in the previous studies promoter activity was ‘pre-
sumed’ based on occupancy of RNA polymerase II,
which is now known to bind both active and ‘paused’
Figure 6 Model of K4-dependent and K4-independent gene silencing in colon cancer. Expressed genes in normal colon mucosa have high
levels of H3K4me3, are DNA hypomethylated at the TSS, and are contained within open chromatin (grey ovals). K4-independent repressed genes
retain appreciable levels of H3K4me3, often acquire repressive histone marks such as H3K27me3, and are often not DNA hypermethylated. Also,
the chromatin at the TSS of K4-independent repressed genes is more condensed than in normal colon. Virtually all of these genes have a CpG
island at the TSS. In comparison, K4-dependent repressed genes lack H3K4me3, are located in highly compacted chromatin, and are DNA
hypermethylated, regardless of the presence of a CpG island. K4-dependent genes also do not acquire repressive chromatin marks.
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promoters that are weakly transcriptionally active
[1,22,23]. Our findings are consistent with more recent
studies showing significant positive correlations between
DNA hypermethylation and low gene activity at CpG-
poor promoters in multiple human tissues [24].
We find it particularly intriguing that K4-dependent
repressed genes, which lack H3K4me3, are apparently
devoid of repressive histone modifications, including
H3K27me3, H3K9me2, and H4K20me3. While we can-
not rule out the possibility that these genes acquire a
currently unknown repressive mark, one possibility is
that the loss of H3K4me3, together with methylation of
residual CpGs, is sufficient for gene silencing in cancer.
Further studies in which H3K4me3 is restored at these
genes’ promoters could help test this hypothesis.
Conclusions
We conclude that the presence of the H3K4me3 mark
at low CpG-content TSSs protects from DNA methyla-
tion and transcriptional repression in colon cancer.
Quantitatively, of transcriptionally repressed genes that
lose H3K4me3 and become DNA hypermethylated in
colon cancer, more typically lack CpG islands than con-
tain CpG islands.
Based on these findings, we propose that CpG-rich
genes repressed by loss of H3K4me3 and DNA methyla-
tion represent rare examples of a more general epige-
netic mechanism of gene repression, one in which
silencing is mediated by loss of H3K4me3 and methyla-
tion of non-CpG island promoter-associated cytosines.
Lastly, we note that the identification of gene silencing
in cancer in association with CpG island methylation
has led to the discovery of 5-azacytidine as a drug able
to reactivate expression of such genes and to the use of
5-azacytidine for cancer treatment. It will similarly be of
interest to seek to identify other pharmacologic agents
that induce re-expression of repressed genes that lack
CpG islands.
Additional material
Additional file 1: Figure S1 - results of H3K4me3 ChIP-chip analysis
at a region on human chromosome 1. The asterisk denotes a signal
that is enlarged on the right.
Additional file 2: Figure S2. (A) Bimodal distribution of expression
levels of genes in SW480, as determined by microarray analysis.
Genes with expression values less than 31 (left of the red line) were
considered ‘off’. Genes with expression values greater than 75 were
considered ‘on’ (right of the blue line). Similar distributions were
observed for all remaining cell lines tested. (B) Scatter plot of expression
correlated with the H3K4me3 levels in SW480. Vertical and horizontal
lines denote the thresholds used for analysis. Similar plots were observed
for all remaining cell lines tested. (C) Quantitative real time PCR
validation of microarray data. Expression data for three K4-independent
(top left) three K4-dependent genes (top right) common to colon cancer
lines SW480 and V429 are plotted relative for both lines and three
control crypts, relative to the averages of the control crypt samples for
each respective gene. Bottom: same for two genes overexpressed in
SW480 and V429 relative to normal crypt samples.
Additional file 3: Figure S3. (A) Quantitative H3K4me3 ChIP of K4-
independent (red) and K4-dependent genes (green) in colon line
SW480 (bottom) and normal colon mucosa (top). The names of the
genes tested are shown at the bottom of each plot. NC corresponds to a
non-target control region. PSMB4 serves as a positive control. (B)
Quantitative H3K27me3 ChIP in SW480, V441, and normal colon mucosa.
K4-independent and -dependent genes are shown in red and green,
respectively. NT, non-target controls.
Additional file 4: Figure S4. (A) Verification of K4-dependent and
K4-independent gene classes using independent ChIP reactions and
NimbleGen 385K promoter arrays. (B) Integrated Genome Browser
view showing exon usage for a gene expressed in SW480 (top) and a
gene designated as repressed in SW480 (bottom). Data for three of five
colon crypt preparations are shown. The y-axis in each of the plots
corresponds to the relative intensity of microarray probes spanning each
exon. The red horizontal lines denote the ‘on’ threshold for expression
and are matched for all samples. Other genes designated as repressed
showed similar results.
Additional file 5: Figure S5. CpG content of K4-dependent and K4-
independent repressed genes. Percentages of K4-dependent and
-independent promoters with CpG islands in each of the colorectal cell
lines are shown. *P < 0.001.
Additional file 6: Table S1. Panther analysis of K4-independent (I)
and K4-dependent (II) genes.
Additional file 7: Figure S6. Tissue specificity and the frequency of
silencing of K4-independent and -dependent genes in colorectal
cancer. (a) All genes were assigned a score based on their specificity of
expression in normal colon, compared to non-colon cells. Low scores
correspond to a high degree of tissue-specificity. Shown in the plot are the
distribution of tissue-specificity scores for K4-dependent and K4-
independent genes, a set of randomly chosen genes, and all genes. Arrows
denote the median scores for each gene set. (b) Histogram of expression
values for K4-dependent and K4-independent genes in a set of 35 colon
cancer lines. Vertical bars in each plot correspond to the median.
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microarray technology; DNAse-seq: DNase I hypersensitive site sequencing;
DNMT: DNA methyltransferase; H3K4me3: histone H3 trimethylated at lysine
4; H3K9me2: histone H3 dimethylated at lysine 9; H4K20me3: histone H4
trimethylated at lysine 20; TSS: transcription start site.
Acknowledgements
This work was supported in part by the following NIH grants: R01HD056369
and R01CA160356 to PCS, and 1P50CA150964 and NIH UO1 CA152756 to
SM. BAZ is a predoctoral student in the Molecular Medicine PhD Program of
Cleveland Clinic and Case Western Reserve University, funded, in part, by the
Med into Grad initiative of the Howard Hughes Medical Institute.
Author details
1Department of Genetics and Genome Sciences, Case Western Reserve
University, 10900 Euclid Ave, Cleveland, OH 44106, USA. 2Department of
Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case
Western Reserve University, 9500 Euclid Ave, Cleveland, OH 44195, USA.
3Institute for Science and Policy, and Department of Pediatrics, Duke
University, 101 Science Drive, Durham, NC 27708, USA. 4Case Comprehensive
Cancer Center, Case Western Reserve University, 11100 Euclid Ave, Cleveland,
OH 44106, USA. 5Department of Pathology, Case Western Reserve University,
2103 Cornell Road, Cleveland, OH 44106, USA. 6Department of Medicine,
Case Western Reserve University, 10900 Euclid Ave Cleveland, OH 44106,
USA.
Authors’ contributions
PCS conceived and designed the experiments. DB performed all ChIP
analyses and 5-azacytidine experiments. DB, LS, and GEC performed the
Balasubramanian et al. Genome Medicine 2012, 4:47
http://genomemedicine.com/content/4/5/47
Page 10 of 11
DNase-seq experiments. JL, JW, LB, and SDM provided samples. MV
performed the expression analyses. BA-Z performed validation experiments.
KG and CFB provided technical assistance. DB, BA-Z, LM, and PCS analyzed
the data. DB, B-AZ, SDM, and PCS wrote the paper. All authors have read
and approved the manuscript for publication.
Competing interests
The authors declare that they have no competing interests.
Received: 1 December 2011 Revised: 13 April 2012
Accepted: 28 May 2012 Published: 28 May 2012
References
1. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA: A chromatin
landmark and transcription initiation at most promoters in human cells.
Cell 2007, 130:77-88.
2. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M,
Schubeler D: Distribution, silencing potential and evolutionary impact of
promoter DNA methylation in the human genome. Nat Genet 2007,
39:457-466.
3. Okitsu CY, Hsieh CL: DNA methylation dictates histone H3K4 methylation.
Mol Cell Biol 2007, 27:2746-2757.
4. Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T: KDM1B
is a histone H3K4 demethylase required to establish maternal genomic
imprints. Nature 2009, 461:415-418.
5. Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, Su H, Sun W, Chang H,
Xu G, Gaudet F, Li E, Chen T: The lysine demethylase LSD1 (KDM1) is
required for maintenance of global DNA methylation. Nat Genet 2009,
41:125-129.
6. Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X: Structure of Dnmt3a
bound to Dnmt3L suggests a model for de novo DNA methylation.
Nature 2007, 449:248-251.
7. Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H,
Tempst P, Lin SP, Allis CD, Cheng X, Bestor TH: DNMT3L connects
unmethylated lysine 4 of histone H3 to de novo methylation of DNA.
Nature 2007, 448:714-717.
8. Willson JK, Bittner GN, Oberley TD, Meisner LF, Weese JL: Cell culture of
human colon adenomas and carcinomas. Cancer Res 1987, 47:2704-2713.
9. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ,
Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS, Collins FS: Genome-wide
analysis of menin binding provides insights into MEN1 tumorigenesis.
PLoS Genet 2006, 2:e51.
10. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey TS,
Crawford GE: High-resolution mapping and characterization of open
chromatin across the genome. Cell 2008, 132:311-322.
11. Li H, Ruan J, Durbin R: Mapping short DNA sequencing reads and calling
variants using mapping quality scores. Genome Res 2008, 18:1851-1858.
12. Boyle AP, Guinney J, Crawford GE, Furey TS: F-Seq: a feature density
estimator for high-throughput sequence tags. Bioinformatics 2008,
24:2537-2538.
13. Pilozzi E, Onelli MR, Ziparo V, Mercantini P, Ruco L: CDX1 expression is
reduced in colorectal carcinoma and is associated with promoter
hypermethylation. J Pathol 2004, 204:289-295.
14. Loh K, Chia JA, Greco S, Cozzi SJ, Buttenshaw RL, Bond CE, Simms LA,
Pike T, Young JP, Jass JR, Spring KJ, Leggett BA, Whitehall VL: Bone
morphogenic protein 3 inactivation is an early and frequent event in
colorectal cancer development. Genes Chromosomes Cancer 2008,
47:449-460.
15. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S,
Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD: Biallelic
inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism
causing human MSI cancers. Proc Natl Acad Sci USA 1998, 95:8698-8702.
16. Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G: DNA
methylation directly silences genes with non-CpG island promoters and
establishes a nucleosome occupied promoter. Hum Mol Genet 2011,
20:4299-4310.
17. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B,
Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL,
Lander ES: A bivalent chromatin structure marks key developmental
genes in embryonic stem cells. Cell 2006, 125:315-326.
18. Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S, Thomas PD: PANTHER
version 7: improved phylogenetic trees, orthologs and collaboration
with the Gene Ontology Consortium. Nucleic Acids Res 2010, 38:D204-210.
19. Schug J, Schuller WP, Kappen C, Salbaum JM, Bucan M, Stoeckert CJ Jr:
Promoter features related to tissue specificity as measured by Shannon
entropy. Genome Biol 2005, 6:R33.
20. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T,
Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP:
Gene silencing in cancer by histone H3 lysine 27 trimethylation
independent of promoter DNA methylation. Nat Genet 2008, 40:741-750.
21. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC,
Liang G, Jones PA, Tanay A: Frequent switching of Polycomb repressive
marks and DNA hypermethylation in the PC3 prostate cancer cell line.
Proc Natl Acad Sci USA 2008, 105:12979-12984.
22. Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF,
Zeitlinger J, Adelman K: RNA polymerase is poised for activation across
the genome. Nat Genet 2007, 39:1507-1511.
23. Core LJ, Waterfall JJ, Lis JT: Nascent RNA sequencing reveals widespread
pausing and divergent initiation at human promoters. Science 2008,
322:1845-1848.
24. Nagae G, Isagawa T, Shiraki N, Fujita T, Yamamoto S, Tsutsumi S, Nonaka A,
Yoshiba S, Matsusaka K, Midorikawa Y, Ishikawa S, Soejima H, Fukayama M,
Suemori H, Nakatsuji N, Kume S, Aburatani H: Tissue-specific
demethylation in CpG-poor promoters during cellular differentiation.
Hum Mol Genet 2011, 20:2710-2721.
doi:10.1186/gm346
Cite this article as: Balasubramanian et al.: H3K4me3 inversely correlates
with DNA methylation at a large class of non-CpG-island-containing
start sites. Genome Medicine 2012 4:47.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Balasubramanian et al. Genome Medicine 2012, 4:47
http://genomemedicine.com/content/4/5/47
Page 11 of 11
